Funding Rounds
Sibylla Biotech

Sibylla Biotech Series A (2022, $22M)

Sibylla Biotech

Small molecule folding interfering degraders (FIDs) that target multiple therapeutic areas.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $22.82M

Raised Date: 2022-01-01

Investors